Company intelligence / Profile preview

Olvos Science

Kifissia, Attica, Greece
Ownership
Private
Employees
~100
Development stage
Other
01

Overview

Olvos Science is a leading Greek healthcare company and a subsidiary of the Galenica Group, specializing in the development, marketing, and distribution of consumer health products and over-the-counter (OTC) medicines. Established in 1994, the company manages a robust portfolio that includes well-known brands in the fields of probiotics, nasal care, and diagnostic testing. Olvos Science is particularly recognized for its Sinomarin nasal care line, which is exported to over 40 countries worldwide. The company's business model combines the commercialization of proprietary products with the strategic distribution of international brands like Clearblue and Heliocare. With a strong focus on the pharmacy channel, Olvos Science provides evidence-based solutions across therapeutic areas such as gastroenterology, respiratory health, and dermatology.

Therapeutic areas
Infectious DiseasesMetabolic DisordersGastroenterologyPulmonologyImmunologyWomen's Health
Modalities
Small moleculeLive biotherapeutic product therapyDeviceBotanical extractBiologic
Industry
Biotech
02

Drug pipeline

1 asset

Cretan IAMA

Unknown
03

Partnerships

Procter & GambleLifeplanHRA PharmaCantabria Labs

Beyond the preview

Go deeper on Olvos Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olvos Science.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call